Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 45
Filtrar
1.
Braz. J. Pharm. Sci. (Online) ; 59: e23063, 2023. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1505837

RESUMO

Abstract Doxorubicin (Dox) is a medication used in the treatment of cancerous tumors and hematologic malignancies with potentially serious side effects, including the risk of cardiotoxicity. Flavonoids are plant metabolites with antioxidant properties and can be extracted from Camellia sinensis (CS). The aim of this study is to evaluate the possible cardioprotective effect of CS against injuries induced by Dox in rats. A total of 32 animals were distributed into four groups: (1) control - intraperitoneal injection (I.P.) of 0.5 mL saline weekly and 1.0 mL water by gavage daily; (2) CS - 0.5 mL saline I.P. weekly and 200 mg/kg CS by gavage daily; (3) Dox - 5.0 mg/kg Dox I.P. weekly and 1.0 mL water by gavage daily; and (4) Dox+CS -5.0 mg/kg Dox I.P. weekly and 200 mg/kg CS by gavage daily. Clinical examinations, blood profiles, electrocardiograms, echocardiograms, and histological analyses of hearts were performed over 25 days. The animals in the Dox group showed changes in body weight and in erythrogram, leukogram, electrocardiography, and echocardiography readings. However, animals from the dox+CS group had significantly less change in body weight, improved cardiac function, and showed more preserved cardiac tissue. This study demonstrated that CS prevents dox-induced cardiotoxicity, despite enhancing the cytotoxic effect on blood cells


Assuntos
Animais , Masculino , Ratos , Doxorrubicina/administração & dosagem , Camellia sinensis/efeitos adversos , Cardiotoxicidade , Ecocardiografia/instrumentação , Neoplasias Hematológicas/patologia , Eletrocardiografia/instrumentação , Antioxidantes/farmacologia
3.
Rev. cuba. estomatol ; 57(1): e2967, ene.-mar. 2020. tab
Artigo em Espanhol | LILACS, CUMED | ID: biblio-1126487

RESUMO

RESUMEN Introducción: El té verde (Camellia sinensis) y el propóleo presentan flavonoides, que inhiben el crecimiento, metabolismo y la coagregación del Streptococcus mutans, principal agente causal de la caries dental. Objetivo: Evaluar la actividad antibacteriana in vitro del extracto etanólico del té verde (Camellia sinensis) al 10 por ciento y 20 por ciento comparado con extracto etanólico de propóleo al 10 por ciento y 20 por ciento, frente al crecimiento de cepas de Streptococcus mutans (ATCC 25175). Métodos: Estudio experimental in vitro, longitudinal, prospectivo y comparativo. El universo estuvo constituido por 90 discos de difusión y la muestra por 15 discos embebidos en té verde (Camellia sinensis) o propóleo a diferentes concentraciones, clorhexidina acuosa al 0,12 por ciento y agua destilada. El tamaño de muestra se calculó por fórmula de comparación de medias, después de realizar un estudio piloto. Se colocaron los discos de difusión embebidos en las sustancias sobre agar Mueller Hinton, sembrado con Streptococcus mutans (ATCC 25175), haciendo medición del ancho de los halos inhibitorios a las 24 y 48 h. Se aplicaron pruebas de comparación no paramétricas de Kruskal Wallis y la prueba rangos de Wilcoxon. Resultados: El máximo ancho de halo inhibitorio logrado por clorhexidina acuosa al 0,12 por ciento, extracto etanólico de té verde (Camellia sinensis) al 20 por ciento y extracto etanólico de propóleo al 20 por ciento fue a las 24 h con valores de 10,64 mm ± 0,924 mm, 6,82 mm ± 0,982 mm y 8,36 mm ± 1,286 mm, respectivamente. El extracto etanólico de té verde (Camellia sinensis) al 20 por ciento, presentó diferencias estadísticamente significativas respecto al extracto etanólico de propóleo al 20 por ciento, tanto a las 24 h (p= 0,013), como a las 48 h (p= 0,011). Conclusiones: Frente al crecimiento de cepas de Streptococcus mutans (ATCC 25175), el extracto etanólico de propóleo al 20 por ciento presenta mayor actividad antibacteriana respecto al extracto etanólico de té verde (Camellia sinensis) al 10 por ciento y 20 por ciento, actividad que disminuye con el paso del tiempo(AU)


ABSTRACT Introduction: Green tea (Camellia sinensis) and propolis contain flavonoids which inhibit the growth, metabolism and co-aggregation of Streptococcus mutans, the main causative agent of dental caries. Objective: Evaluate the antibacterial activity in vitro of 10 percent and 20 percent green tea (Camellia sinensis) ethanolic extract versus 10 percent and 20 percent propolis ethanolic extract against the growth of Streptococcus mutans (ATCC 25175) strains. Methods: An in vitro experimental prospective longitudinal comparative study was conducted. The study universe was 90 diffusion disks and the sample was 15 disks soaked up in green tea (Camellia sinensis) or propolis at various concentrations, 0.12 percent aqueous chlorhexidine and distilled water. Sample size was estimated by the comparison of means formula after conducting a pilot study. The diffusion disks soaked up in the substances were placed on Mueller Hinton agar planted with Streptococcus mutans (ATCC 25175) and the width of the inhibition haloes was measured at 24 h and 48 h. Nonparametric Kruskal-Wallis comparison tests and the Wilcoxon rank test were performed. Results: The maximum width of the inhibition halo achieved by 0.12 percent aqueous chlorhexidine, 20 percent green tea (Camellia sinensis) ethanolic extract, and 20 percent propolis ethanolic extract at 24 h was 10.64 mm ± 0.924 mm, 6.82 mm ± 0.982 mm and 8.36 mm ± 1.286 mm, respectively. The 20 percent green tea (Camellia sinensis) ethanolic extract showed statistically significant differences with respect to the 20 percent propolis ethanolic extract, both at 24 h (p= 0.013) and at 48 h (p= 0.011). Conclusions: The 20 percent propolis ethanolic extract displays greater antibacterial activity against the growth of Streptococcus mutans (ATCC 25175) strains than the 10 percent and 20 percent green tea (Camellia sinensis) ethanolic extract. This activity decreases with the passing of time(AU)


Assuntos
Humanos , Própole/uso terapêutico , Streptococcus mutans/citologia , Clorexidina/uso terapêutico , Camellia sinensis/efeitos adversos , Antibacterianos/efeitos adversos , Estudos Prospectivos , Estudos Longitudinais
4.
Arch Argent Pediatr ; 117(6): e655-e658, 2019 12 01.
Artigo em Espanhol | MEDLINE | ID: mdl-31758905

RESUMO

Herb-induced liver injury is a type of adverse drug reaction related to using herbal medicine, and now is a segment of druginduced liver injury. The use of herbal products has increased significantly, because it is generally regarded as safe and natural by the public. In the United States, the incidence reaches 9 % and, in the countries of Asia, 19-63 % of the total cases of druginduced liver injury. Green tea is obtained from the leaves of the Camellia sinensis. Freshly harvested leaves are stabilized by dry heating to inactivate the polyphenol enzyme and then dried quickly. Its consumption has increased in recent years and has been reported with hepatotoxic reactions. We present a case of severe hepatitis related to the consumption of green tea in a 2-year-old child.


El daño hepático inducido por hierbas es una reacción adversa relacionada con el uso de medicina herbaria, incluida en el grupo de daño hepático inducido por drogas. El uso terapéutico de hierbas medicinales es cada vez más frecuente por la creencia de que los productos naturales o hierbas son siempre seguros. En Estados Unidos, la incidencia de toxicidad alcanza un 9 % y, en países de Asia, un 19-63 % de los casos totales de daño hepático inducido por drogas. El té verde es obtenido de las hojas de la Camellia sinensis. Las hojas recién cosechadas son estabilizadas por calentamiento en seco para inactivar la enzima polifenol y luego se secan rápidamente. Su consumo ha aumentado en los últimos años, y se han documentado reacciones hepatotóxicas. Se presenta un caso de hepatitis aguda grave asociada al consumo de té verde en un niño de 2 años.


Assuntos
Camellia sinensis/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Hepatite/etiologia , Chá/efeitos adversos , Camellia sinensis/química , Doença Hepática Induzida por Substâncias e Drogas/patologia , Pré-Escolar , Hepatite/patologia , Humanos , Masculino , Índice de Gravidade de Doença , Chá/química
6.
Braz. j. biol ; 78(4): 673-678, Nov. 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-951612

RESUMO

Abstract Amphotericin B is a fungicidal substance that is treatment of choice for most systemic fungal infections affecting immunocompromised patients. However, severe side effects have limited the utility of this drug. The aim of this study was to evaluate the antifungal effect of the combination of amphotericin B with black tea or white tea and protective of citotoxic effect. The present study shows that white and black teas have additive effects with amphotericin B against some species Candida. In addition, the combination of white and black tea with amphotericin B may reduce the toxicity of amphotericin B to red blood cells. Our results suggest that white and black tea is a potential agent to combine with amphotericin for antifungal efficacy and to reduce the amphotericin dose to lessen side effects.


Resumo A anfotericina B é o tratamento de escolha para a maioria das infecções fúngicas sistémicas que afetam os doentes imunocomprometidos. No entanto, efeitos secundários graves têm limitado a utilidade desta droga. O objetivo deste estudo foi avaliar o efeito antifúngico da combinação de anfotericina B com chá preto ou chá branco, bem como o efeito citotóxico desta combinação sobre hemáceas. O presente estudo demonstra que o chá branco e preto de Camellia sinensis têm efeitos aditivos com anfotericina B contra algumas espécies de Candida sp. Além disso, a combinação de chá branco e preto com anfotericina B pode reduzir a toxicidade da anfotericina B em hemáceas. Nossos resultados sugerem que o chá branco e preto são agentes potenciais para associação com anfotericina B contribuindo para eficácia antifúngica, bem como redução de toxicidade.


Assuntos
Humanos , Candida/efeitos dos fármacos , Anfotericina B/farmacologia , Camellia sinensis/efeitos adversos , Eritrócitos/efeitos dos fármacos , Antifúngicos/farmacologia , Anfotericina B/efeitos adversos , Hemólise/efeitos dos fármacos , Antifúngicos/efeitos adversos
7.
J Food Drug Anal ; 26(2S): S72-S77, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29703388

RESUMO

Many patients treated with cardiovascular (CV) drugs drink green tea (GT), either as a cultural tradition or persuaded of its putative beneficial effects for health. Yet, GT may affect the pharmacokinetics and pharmacodynamics of CV compounds. Novel GT-CV drug interactions were reported for rosuvastatin, sildenafil and tacrolimus. Putative mechanisms involve inhibitory effects of GT catechins at the intestinal level on influx transporters OATP1A2 or OATP2B1 for rosuvastatin, on CYP3A for sildenafil and on both CYP3A and the efflux transporter p-glycoprotein for tacrolimus. These interactions, which add to those previously described with simvastatin, nadolol and warfarin, might lead, in some cases, to reduced drug efficacy or risk of drug toxicity. Oddly, available data on GT interaction with CV compounds with a narrow therapeutic index, such as warfarin and tacrolimus, derive from single case reports. Conversely, GT interactions with simvastatin, rosuvastatin, nadolol and sildenafil were documented through pharmacokinetic studies. In these, the effect of GT or GT derivatives on drug exposure was mild to moderate, but a high inter-individual variability was observed. Further investigations, including studies on the effect of the dose and the time of GT intake are necessary to understand more in depth the clinical relevance of GT-CV drug interactions.


Assuntos
Camellia sinensis/química , Fármacos Cardiovasculares/farmacologia , Interações Medicamentosas , Chá/efeitos adversos , Animais , Camellia sinensis/efeitos adversos , Fármacos Cardiovasculares/efeitos adversos , Humanos , Transportadores de Ânions Orgânicos/genética , Transportadores de Ânions Orgânicos/metabolismo , Chá/química
9.
Pediatrics ; 140(4)2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28864554

RESUMO

Isotretinoin is the most effective acne therapy available, but has the potential for a number of adverse side effects, including transaminitis. The iPLEDGE isotretinoin program recommends avoiding some herbals and supplements due to potential side effects. However, little is known about the effects of protein supplements on the liver, particularly in patients taking isotretinoin. We designed a retrospective chart review to evaluate the symptoms, diagnosis, treatment, and outcome of patients on or preparing to take isotretinoin therapy who were concurrently ingesting protein or herbal supplementation and who developed transaminitis. In 100% (8/8) of cases, dietary supplementation was determined to be at least a possible cause of elevated liver transaminases. In 75% (6/8) of cases, dietary supplement appears to be the most likely cause at some point in their evaluation. Most of our patients' elevations in aspartate aminotransferase and/or alanine aminotransferase were likely caused by supplementation with protein, creatine, or herbal extracts, rather than prescribed isotretinoin or tetracycline antibiotics for acne. Hence, dietary supplementation may cause liver function abnormalities. As supplement usage appears common in teenagers, clinicians should consider counseling their patients to avoid these products, particularly when prescribing known hepatotoxic drugs.


Assuntos
Acne Vulgar/tratamento farmacológico , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Fármacos Dermatológicos/efeitos adversos , Suplementos Nutricionais/efeitos adversos , Isotretinoína/efeitos adversos , Adolescente , Biomarcadores/metabolismo , Camellia sinensis/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/diagnóstico , Doença Hepática Induzida por Substâncias e Drogas/enzimologia , Creatina/efeitos adversos , Fármacos Dermatológicos/uso terapêutico , Proteínas na Dieta/efeitos adversos , Feminino , Seguimentos , Humanos , Isotretinoína/uso terapêutico , Masculino , Preparações de Plantas/efeitos adversos , Estudos Retrospectivos , Transaminases/metabolismo , Resultado do Tratamento
10.
Food Res Int ; 99(Pt 1): 72-83, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28784536

RESUMO

Matcha tea is gaining popularity throughout the world in recent years and is frequently referred to as a mood-and-brain food. Previous research has demonstrated that three constituents present in matcha tea, l-theanine, epigallocatechin gallate (EGCG), and caffeine, affect mood and cognitive performance. However, to date there are no studies assessing the effect of matcha tea itself. The present study investigates these effects by means of a human intervention study administering matcha tea and a matcha containing product. Using a randomized, placebo-controlled, single-blind study, 23 consumers participated in four test sessions. In each session, participants consumed one of the four test products: matcha tea, matcha tea bar (each containing 4g matcha tea powder), placebo tea, or placebo bar. The assessment was performed at baseline and 60min post-treatment. The participants performed a set of cognitive tests assessing attention, information processing, working memory, and episodic memory. The mood state was measured by means of a Profile of Mood States (POMS). After consuming the matcha products compared to placebo versions, there were mainly significant improvements in tasks measuring basic attention abilities and psychomotor speed in response to stimuli over a defined period of time. In contrast to expectations, the effect was barely present in the other cognitive tasks. The POMS results revealed no significant changes in mood. The influence of the food matrix was demonstrated by the fact that on most cognitive performance measures the drink format outperformed the bar format, particularly in tasks measuring speed of spatial working memory and delayed picture recognition. This study suggests that matcha tea consumed in a realistic dose can induce slight effects on speed of attention and episodic secondary memory to a low degree. Further studies are required to elucidate the influences of the food matrix.


Assuntos
Afeto/efeitos dos fármacos , Cafeína/administração & dosagem , Camellia sinensis , Catequina/análogos & derivados , Cognição/efeitos dos fármacos , Glutamatos/administração & dosagem , Lanches , Chá , Adulto , Atenção/efeitos dos fármacos , Cafeína/efeitos adversos , Camellia sinensis/efeitos adversos , Catequina/administração & dosagem , Catequina/efeitos adversos , Feminino , Glutamatos/efeitos adversos , Humanos , Masculino , Memória/efeitos dos fármacos , Países Baixos , Desempenho Psicomotor/efeitos dos fármacos , Método Simples-Cego , Análise e Desempenho de Tarefas , Chá/efeitos adversos , Fatores de Tempo , Adulto Jovem
11.
Toxicol Lett ; 277: 104-108, 2017 Aug 05.
Artigo em Inglês | MEDLINE | ID: mdl-28655517

RESUMO

The safety of green tea infusions and green tea extract (GTE)-based products is reviewed regarding catechins. Epigallocatechin 3-gallate (EGCG), the major catechin present in green tea, is suspected of being responsible for liver toxicity reported in humans consuming food supplements. Intake of EGCG with green tea infusions and GTE-based beverages is up to about 450mg EGCG/person/day in Europe and higher in Asia. Consumption of green tea is not associated with liver damage in humans, and green tea infusion and GTE-based beverages are considered safe in the range of historical uses. In animal studies, EGCG's potency for liver effects is highly dependent on conditions of administration. Use of NOAELs from bolus administration to derive a tolerable upper intake level applying the margin of safety concept results in acceptable EGCG-doses lower than those from one cup of green tea. NOAELs from toxicity studies applying EGCG with diet/split of the daily dose are a better point of departure for risk characterization. In clinical intervention studies, liver effects were not observed after intakes below 600mg EGCG/person/day. Thus, a tolerable upper intake level of 300mg EGCG/person/day is proposed for food supplements; this gives a twofold safety margin to clinical studies that did not report liver effects and a margin of safety of 100 to the NOAELs in animal studies with dietary administration of green tea catechins.


Assuntos
Camellia sinensis/química , Catequina/análogos & derivados , Suplementos Nutricionais , Inocuidade dos Alimentos , Extratos Vegetais/análise , Chá/química , Chás de Ervas/análise , Animais , Camellia sinensis/efeitos adversos , Catequina/efeitos adversos , Catequina/análise , Qualidade de Produtos para o Consumidor , Suplementos Nutricionais/efeitos adversos , Análise de Perigos e Pontos Críticos de Controle , Humanos , Nível de Efeito Adverso não Observado , Extratos Vegetais/efeitos adversos , Recomendações Nutricionais , Medição de Risco , Chá/efeitos adversos , Chás de Ervas/efeitos adversos
13.
J Med Food ; 19(3): 330-6, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26987026

RESUMO

The article presents an evaluation of the safety of yellow tea (Camellia sinensis) extract consumption and its antioxidant activity in an animal model. Wistar rats were exposed through diet to 2, 6, and 10 g yellow tea extract/kg feed for 90 days. No signs of toxicity and no differences in mean body weight gain in the treated and control rats were recorded throughout the experiment. No statistically significant differences in hematology findings and clinical chemistry parameters were observed between controls and treated groups. Microscopic examination of tissue sections revealed no pathology attributable to yellow tea extract intake. Lipid peroxidation level in the liver was slightly increased in medium-dose males and high-dose females and decreased in two female groups receiving 2 and 6 g/kg of the extract tested. Content of carbonyl groups in protein, as well as the basal level of DNA damage, was not changed. In a majority of rats, the activity of antioxidant enzymes was increased except superoxide dismutase in high-dose groups, glutathione peroxidase in high-dose females, glutathione reductase in low- and mid-dose groups, and glutathione S-transferase in mid-dose females and high-dose males. It could be concluded that rats tolerated well dietary treatment with yellow tea extract up to 0.8 g/kg b.w./day for 90 days. Results showed that yellow tea extract at the doses tested did not demonstrate adverse effects and improved the antioxidant status in the liver of rats.


Assuntos
Antioxidantes/metabolismo , Camellia sinensis/metabolismo , Extratos Vegetais/metabolismo , Animais , Antioxidantes/efeitos adversos , Camellia sinensis/efeitos adversos , Camellia sinensis/química , Feminino , Glutationa Peroxidase/metabolismo , Glutationa Redutase/metabolismo , Glutationa Transferase/metabolismo , Fígado/efeitos dos fármacos , Fígado/enzimologia , Masculino , Extratos Vegetais/efeitos adversos , Ratos , Ratos Wistar , Superóxido Dismutase/metabolismo
14.
Rev. Salusvita (Online) ; 35(1): 41-51, 2016. tab
Artigo em Inglês | LILACS | ID: lil-788579

RESUMO

Introduction: mechanical hygiene is still the best method forthe maintenance of oral health and prevention of biofilm formation. However, mouthrinses have been increasingly used as an adjunct support especially for post-operatory conditions or when periodontal conditions require. In this way, a number of mouthrinses are available, presenting different active ingredients with predominant antimicrobial action. Objectives: the aim of the present study was to evaluate the topical action of a green-tea extract-based mouthwash on gingival tissue. Materials and Methods: a longitudinal double-blind comparison was performed with two groups of patients clinically evaluated and diagnosed as suffering from gingivitis (n= 40). The patients were divided into two groups, according to the mouthrinse used: GT - green tea (concentration of 20mg/ml), and P - placebo, 0.9% saline solution. Clinical examination of the mucosa, tooth staining, plaque and gingival indices were peformed before and 15 days after the continuous use of the products twice a day. Results: no mucosal or tasting alterations were found, neither tooth staining regardless the mouthrinse used. Statistical assessment did not detect differences on gingival indexes between the groups before and after mouthrinses use; however, plaque indexes were significant lower in patients of GT group, compared to the P group. Conclusions: the use of phytotherapic products with active ingredients should be investigated for biofilm control, responsible for the onset and progression of periodontal disease, as well as other various oral pathologies. Considering the period of evaluation pro-posed in this study, relevant decrease in initial phase of plaque for-mation could be observed with the green tea mouthrinse. Further long-term evaluation studies should be carried-out in order to eluci-date its continuous effects on oral structures.


Introdução: higiene mecânica ainda é o melhor método para a manutenção da saúde bucal e prevenção da formação de biofilmes. No entanto, enxagues têm sido cada vez mais usado como um suporte auxiliar especialmente para as condições pós-operatórias ou quando as condições periodontais exigem. Desta forma, um número de bochechos estão disponíveis, apresentando diferentes ingredientes ativos com predominante ação antimicrobiana. Objetivos: o objetivo do presente estudo foi avaliar a ação tópica de um bochecho à base de extrato de chá verde no tecido gengival. Materiais e Métodos: a comparação longitudinal, duplo-cego, foi realizada com dois grupos de pacientes clinicamente avaliados e diagnosticados como portadores de gengivite (n = 40). Os pacientes foram divididos em dois grupos, de acordo com o enxaguatório oral usado: CV - chá verde (concentração de 20 mg / ml), e P - placebo, solução salina a 0,9%. O exame clínico da mucosa, coloração dos dentes, índice de placa e índice gengival foram realizados antes e 15 dias após o uso contínuo dos produtos duas vezes por dia. Resultados: nenhuma alteração na mucosa ou de degustação foi encontrada, assim como não foi identificado modificação na coloração do dente. A Avaliação estatística não detectou diferenças no índice gengival entre os grupos antes e depois de usar enxaguatórios. No entanto, índice de placa inferior foi menor de forma significativa nos pacientes do grupo CV, em comparação com o grupo P. Conclusões: o uso de produtos fitoterápicos com ingredientes ativos deve ser investigado para o controle de biofilme, responsável pelo aparecimento e progressão da doença periodontal. Considerando o período de avaliação proposto, a redução correspondente na fase inicial da formação de placa pôde ser observada com o enxaguatório à base de chá verde. Além disso, estudos de avaliação de longo prazo devem ser realizados, a fim de elucidar seu efeito contínuo em longo prazo sobre as estruturas orais.


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Gengivite/tratamento farmacológico , Antissépticos Bucais/análise , Antissépticos Bucais/uso terapêutico , Extratos Vegetais/uso terapêutico , Método Duplo-Cego , Camellia sinensis/efeitos adversos
15.
BMJ Case Rep ; 20152015 Sep 23.
Artigo em Inglês | MEDLINE | ID: mdl-26400588

RESUMO

A previously healthy 16-year-old girl presented with signs of acute hepatitis. On initial enquiry, she had not taken any prescribed or 'over-the-counter' medications, and there was no recent travel history. Further investigations revealed no viral, autoimmune or metabolic cause of hepatitis. Only following specific questioning did she reveal that she had, in the preceding 3 months, regularly consumed internet ordered Chinese green tea, which contained Camellia sinensis. After ceasing green tea consumption, there was a rapid and sustained recovery of her hepatitis. The authors discuss the probable cause of herbal tea in this case of acute hepatitis, and the importance of awareness of this rare yet recurring theme for patients and clinicians alike.


Assuntos
Camellia sinensis/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Hepatite/etiologia , Extratos Vegetais/efeitos adversos , Chá/efeitos adversos , Doença Aguda , Adolescente , Camellia sinensis/química , Catequina/análogos & derivados , Catequina/isolamento & purificação , Doença Hepática Induzida por Substâncias e Drogas/fisiopatologia , Feminino , Hepatite/fisiopatologia , Humanos , Extratos Vegetais/química , Recidiva , Resultado do Tratamento
16.
J Food Sci ; 80(3): T659-63, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25676191

RESUMO

Epigallocatechin-3-gallate (EGCG) is the major and most potent representative in green tea, which has been proved to modulate myocardial contractility. Whether EGCG has some negative effects on cardiac function is not known. In the present study, we investigated the effects of EGCG at different doses on cardiac contraction and explored whether ß2 -adrenoceptor (ß2 AR) was involved in EGCG-induced cardiac effects. Isolated rat hearts were mounted on the Langendorff system and perfused with different concentrations of EGCG in low or normal calcium Krebs-Henseleit (KH) buffer. The contraction of hearts was measured. Ventricular myocytes were cultured with EGCG and isoprenaline (ISO, 10(-7) M) for 12 h. ICI118,551 (55 nM) was used to inhibit ß2 AR. Cardiomyocyte shortening, viability, and responsiveness to ISO (10(-9) M) were measured. EGCG dose dependently enhanced contractility of perfused heart in low calcium KH buffer. In the normal calcium KH buffer, EGCG at low dose (20 µM) increased heart contraction, while at high dose (50 µM), it increased the incidences of arrhythmia and diastolic dysfunction. In isolated ventricular myocytes, EGCG at the concentration of 0.001 to 1.0 µΜ did not affect their contraction. However, the responsiveness to ISO and the survival of myocytes were increased by EGCG (0.01 µM). The increased responsiveness was partially abolished by ICI118,551. The data obtained in this study demonstrated that EGCG at low dose conferred cardioprotection, yet at high dose increased the incidences of arrhythmia and diastolic dysfunction. ß2 AR was involved in EGCG-induced cardiac effects.


Assuntos
Arritmias Cardíacas/etiologia , Camellia sinensis/química , Catequina/análogos & derivados , Coração/efeitos dos fármacos , Miocárdio/citologia , Miócitos Cardíacos/efeitos dos fármacos , Receptores Adrenérgicos/metabolismo , Animais , Camellia sinensis/efeitos adversos , Catequina/administração & dosagem , Catequina/efeitos adversos , Glucose , Masculino , Contração Muscular/efeitos dos fármacos , Miocárdio/metabolismo , Extratos Vegetais/administração & dosagem , Extratos Vegetais/efeitos adversos , Ratos , Ratos Sprague-Dawley , Chá , Trometamina
18.
Rev. esp. enferm. dig ; 106(8): 552-555, sept.-dic. 2014. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-130579

RESUMO

La toxicidad hepática asociada al uso de productos de herboristería y suplementos nutricionales es un fenómeno creciente. En la literatura se han comunicado varios casos de hepatitis tóxica en relación con productos utilizados para la pérdida de peso que incluyen extractos de té verde en su composición. A continuación se describen tres casos de hepatotoxicidad relacionados con la toma de Inneov masa capilar®, un suplemento nutricional destinado a detener la caída del cabello cuyo componente principal son las catequinas de té verde. En todos ellos se descartaron otras posibles causas de hepatitis aguda. Recalcamos la importancia de incluir la ingesta de este tipo de sustancias a la hora de realizar la anamnesis para poder detectar y notificar las reacciones hepáticas adversas secundarias a productos herbales de apariencia inocua, como el descrito en el manuscrito (AU)


Liver toxicity associated with herbal remedies and dietary supplements is an increasing concern. Several toxic hepatitis cases have been reported in the literature in association with products intended for weight loss where green tea extracts are an ingredient. Three hepatotoxicity cases are reported below in association with the use of Inneov masa capilar®, a dietary supplement intended to stop hair loss whose primary component is green tea catechins. In all of them, other potential causes of acute hepatitis were ruled out. We highlight the importance of awareness regarding these substances at history taking in order to identify and report hepatic adverse reactions secondary to apparently safe herbs as described in the present manuscript (AU)


Assuntos
Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Suplementos Nutricionais/efeitos adversos , Suplementos Nutricionais/toxicidade , Suplementos Nutricionais , Hepatite/complicações , Camellia sinensis/efeitos adversos , Camellia sinensis/toxicidade , Testes de Toxicidade , Toxicidade/efeitos adversos
19.
Dig Liver Dis ; 46(3): 264-9, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24315480

RESUMO

BACKGROUND: Positive re-exposure tests are diagnostic hallmarks for hepatotoxicity. OBJECTIVE: To test validity of positive re-exposures in herb induced liver injury. METHODS: We searched Medline database for cases of herb induced liver injury with positive re-exposures and analysed 34 cases for positive re-exposure test criteria of baseline alanine aminotransferase< 5N before re-exposure, and re-exposure alanine aminotransferase ≥ 2× baseline alanine aminotransferase. Re-exposure test was negative, if baseline alanine aminotransferase< 5N combined with re-exposure alanine aminotransferase< 2× baseline alanine aminotransferase, or if baseline alanine aminotransferase≥ 5N regardless of the re-exposure alanine aminotransferase including no available re-exposure alanine aminotransferase result. RESULTS: In 21/34 cases (61.8%), criteria for a positive re-exposure were fulfilled, with negative tests in 6/34 cases (17.6%) or uninterpretable ones in 7/34 cases (20.6%). Confirmed positive re-exposure tests established potential of herb induced liver injury for Aloe, Chaparral, Chinese herbal mixtures, Chinese Jin Bu Huan, Chinese Syo Saiko To, Germander, Greater Celandine, Green tea, Kava, Mistletoe, Polygonum multiflorum, and Senna, with up to 4 case reports per herb. CONCLUSIONS: Among 34 cases of herb-induced liver injury with initially reported positive re-exposure tests, 61.8% of the cases actually fulfilled established test criteria and provided firm diagnoses of herb induced liver injury by various herbs.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/diagnóstico , Medicamentos de Ervas Chinesas/efeitos adversos , Plantas Medicinais/efeitos adversos , Alanina Transaminase/sangue , Aloe/efeitos adversos , Bupleurum/efeitos adversos , Camellia sinensis/efeitos adversos , Chelidonium/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/enzimologia , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Feminino , Humanos , Kava/efeitos adversos , Masculino , Erva-de-Passarinho/efeitos adversos , Polygonum/efeitos adversos , Reprodutibilidade dos Testes , Senna (Planta)/efeitos adversos , Teucrium/efeitos adversos
20.
Artigo em Inglês | MEDLINE | ID: mdl-23906092

RESUMO

The dissipation behaviour of three neonicotinoids - thiamethoxam, imidacloprid and acetamiprid - was compared in tea shoots, in Chinese green and black tea, and after tea infusion in hot water. The simple and rapid analytical procedures for the quantification of these three residues in these matrices were developed using HPLC with ultraviolet (UV) detection. Degradation rates in tea shoots of neonicotinoids applied in either recommended or double dosages followed first-order kinetics, with half-lives of 1.62 or 1.58 days for thiamethoxam, of 2.45 or 2.67 days for imidacloprid, and of 3.24 or 3.85 days for acetamiprid, respectively. Through harvest and processing the residue retentions for thiamethoxam, imidacloprid and acetamiprid were 85.0%, 84.1% and 70.6% of the initial dosages in green tea, and 77.1%, 52.4% and 57.4% in black tea. These three residues all showed high transfer rates through green or black tea brewing of 80.5% or 81.6% for thiamethoxam, of 63.1% or 62.2% for imidacloprid, and of 78.3% or 80.6% for acetamiprid. Waiting periods between the last application and harvest of at least 12, 17 and 20 days were suggested for thiamethoxam, imidacloprid and acetamiprid, respectively, after application at their recommend dosages to ensure levels below a maximum residue limit (MRL) of 0.05 mg kg(-1).


Assuntos
Contaminação de Alimentos/análise , Inseticidas/análise , Chá/química , Camellia sinensis/efeitos adversos , Camellia sinensis/química , China , Manipulação de Alimentos , Humanos , Imidazóis/efeitos adversos , Imidazóis/análise , Inseticidas/efeitos adversos , Neonicotinoides , Nitrocompostos/efeitos adversos , Nitrocompostos/análise , Oxazinas/efeitos adversos , Oxazinas/análise , Resíduos de Praguicidas/efeitos adversos , Resíduos de Praguicidas/análise , Piridinas/efeitos adversos , Piridinas/análise , Chá/efeitos adversos , Tiametoxam , Tiazóis/efeitos adversos , Tiazóis/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...